December 2018 Advocacy Day
We had a dynamic group of kidney cancer patient advocates meet in Washington, DC to attend an educational seminar and briefing on policy advocacy issues impacting the kidney cancer community. Hosted by Bryan Lewis, Kidney Cancer Action Network and Kidney Cancer Coalition, we had an ‘inside the beltway’ discussion on the current political landscape including updates on the appropriations process, the NIH/NCI funding, the Congressionally Directed Medical Research Program (CDMRP) and the Kidney Cancer Research Program (KCRP) in particular. Patient advocates were able to craft their stories and prepare for meetings with Hill staffers after hearing what to expect and how to deliver a strong message on behalf of the kidney cancer community.
IT IS OFFICIAL! $20 MILLION FOR KIDNEY CANCER RESEARCH
On September 28th, 2017 the President signed into law the Defense, Labor HHS spending package. Included within this historic bill is the Defense Health Program that has increased the funding for the Kidney Cancer Research Program pursuant to the CDMRP from $15 million to $20 million annually.
The Kidney Cancer Coalition and The Kidney Cancer Action network led the charge for the increase to this important program.
LINK – CDMRP: Congressionally Directed Medical Research Programs
LINK – United States Senate Committee